Evidence map›Paper›PMID 9846976›Full record

ArticleThe American journal of pathology1998

Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition.

C M Hogaboam, C S Gallinat, C Bone-Larson, S W Chensue, N W Lukacs, R M Strieter, S L Kunkel

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice.American journal of respiratory cell and molecular biology · 2009
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Fibrotic disease and the T(H)1/T(H)2 paradigm.Nature reviews. Immunology · 2004
    Review
  20. Blockade of CCR2 ameliorates progressive fibrosis in kidney.The American journal of pathology · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

C M HogaboamDepartment of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA. hogaboam@path.med.umich.edu
C S Gallinat
C Bone-Larson
S W Chensue
N W Lukacs
R M Strieter
S L Kunkel
Veterans Health Administration · USUniversity of Michigan–Ann Arbor · US

Funding

MONONUCLEAR LEUKOCYTE ADHESION AND RECRUITMENT IN CHRONIC INFLAMMATORY DISEASEP01HL031963 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHNSON, KENT JOHN · 1985 to 2009
$14.1M
SCOR IN THE PATHOBIOLOGY OF FIBROTIC LUNG DISEASEP50HL056402 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SIMON, RICHARD H · 1997 to 2006
$13.3M
The Role of C-C Chemokines in Eosinophil Airway InflammationR01AI036302 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 2001 to 2018
$5.6M
MONOCYTE/MACROPHAGE SIGNALS IN LUNG GRANULOMAR37HL035276 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KUNKEL, STEVEN LYNN · 1996 to 2005
$1.4M
C-C CHEMOKINES AND EOSINOPHIL AIRWAY INFLAMMATIONR29AI036302 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 1996 to 2000
$107k
MONOCYTE/MACROPHAGE SIGNALS IN LUNG GRANULOMAR01HL035276 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KUNKEL, STEVEN LYNN · 1987 to 1996
–
NHLBI NIH HHS 1P50HL56402NHLBI NIH HHS HL31963NHLBI NIH HHS HL35276NHLBI NIH HHS P01 HL031963NHLBI NIH HHS P50 HL056402NHLBI NIH HHS R37 HL035276NIAID NIH HHS R01 AI036302NIAID NIH HHS R29 AI036302
6 · The paper itself

Abstract

Recent studies support the concept that pulmonary granulomatous inflammation directed by interferon (IFN)-gamma, interleukin (IL)-12, and nitric oxide usually resolves in the absence of fibrosis. To determine whether nitric oxide participates in modulating the fibrotic response during the development of pulmonary granulomas in response to purified protein derivative (PPD), mice presensitized to PPD received daily intraperitoneal injections of N(G)-nitro-D-arginine-methyl ester (D-NAME), N(G)-nitro-L-arginine-methyl ester (L-NAME), or aminoguanidine after delivery of PPD-coated beads to the lungs. Eight days later, morphometric analysis of lung granulomas revealed that L-NAME-treated mice when challenged with PPD in vitro for 36 hours had the largest pulmonary granulomas and the greatest collagen deposition among the treated groups. In addition, equivalent numbers of dispersed lung cells from L-NAME- and aminoguanidine-treated mice produced significantly higher levels of IL-4, monocyte chemoattractant protein (MCP)-1, and macrophage inflammatory protein (MIP)-1alpha and significantly lower levels of eotaxin compared with D-NAME-treated mice. Cultures of dispersed lung cells from L-NAME-treated mice also produced significantly more IL-10 and less IL-12 compared with similar numbers of dispersed lung cells from D-NAME-treated mice. Cultures of isolated lung fibroblasts from L-NAME-treated mice expressed higher levels of C-C chemokine receptor 2 (CCR2) and CCR3 mRNA and contained less MCP-1 and eotaxin protein than a similar number of fibroblasts from D-NAME-treated mice. Thus, nitric oxide appears to regulate the deposition of extracellular matrix in lung granulomas through the modulation of the cytokine and chemokine profile of these lesions. Alterations in the cytokine, chemokine, and procollagen profile of this lesion may be a direct effect of nitric oxide on the pulmonary fibroblast and provide an important signal for regulating fibroblast activity during the evolution of chronic lung disease.

Indexed as

Chemokines, CCAnimalsCells, CulturedChemokine CCL11Chemokine CCL2Chemokine CCL3Chemokine CCL4CollagenCytokinesEnzyme InhibitorsFemaleFibroblastsGranuloma, Respiratory TractGuanidinesInterferon-gammaInterleukinsCcl11 protein, mouseCcr2 protein, mouseCcr3 protein, mouseChemokine CCL11Chemokine CCL2Chemokine CCL3Chemokine CCL4Chemokines, CCCollagenCytokinesEnzyme InhibitorsGuanidinesInterferon-gammaInterleukinsMacrophage Inflammatory ProteinsNG-Nitroarginine Methyl EsterNitric OxidepimagedineProcollagenReceptors, CCR2Receptors, CCR3Receptors, ChemokineTransforming Growth Factor betaTuberculin

Identifiers

PMID9846976
PMCPMC1866342
OpenAlexW1993151719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.